A new vaccine that has raised hopes of becoming a potent new tool in the battle against malaria seems to stop working in children after four years, according to research published recently. The vaccine candidate –...
U.S. researchers say a vaccine based on genetically engineered DNA could induce an immune response in humans to protect against malaria parasite infection. The PATH Malaria Vaccine Initiative U.S. researchers say a...
The world has an “historic opportunity” to contain and end three of humanity’s deadliest scourges by focusing on their “hot zones,” according to Mark Dybul, the newly appointed director of...
Substantial over-diagnosis and mistreatment of malaria is evident in south and central Asia, according to research led by the London School of Hygiene & Tropical Medicine . The authors warn that with more than two...
Malaria parasites evolving in vaccinated laboratory mice become more virulent, according to research at Penn State University. The mice were injected with a critical component of several candidate human malaria vaccines...
After clean water, vaccines may have saved more lives than any other public health intervention. Eradication of malaria, a disease that may have killed more humans than any other single cause, likely requires a malaria...
World-first screening by scientists at the Queensland Institute of Medical Research has identified new potential treatments for blocking malaria transmission. The QIMR team, in conjunction with Griffith University...
A potential malaria vaccine produced by genetically-engineered algae could allow people to grow their own vaccine at homes, and would be especially useful in rural parts of the developing world, say its developers. The...
It is difficult to overstate how much the fight against infectious diseases has improved the human condition in the last century. In research released today, for Copenhagen Consensus 2012, economists Dean Jamison...
Genocea Biosciences recently announced that it will highlight the development of a new malaria vaccine at an upcoming presentation at the World Vaccine Congress. Dr. Jessica Baker Fletcher, Genocea’s vice president of...